retatrutide clinical trial safety results Retatrutide vs Ozempic: Trial Comparisons Investigating the “efficacy and safety

If they persist, your doctor may adjust your dosage or suggest dietary changes to ease the symptoms

Outstanding Questions GLP-1RA is a new type of drug for the treatment of T2MD

Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and breastfeeding

GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease

When speaking to your GP or specialist, consider raising the following: Your weight management goals and what evidence-based options are available Any supplements or compounds you are currently using or considering Symptoms you may already be experiencing that could indicate metabolic or hormonal imbalance Your eligibility for NHS-funded obesity treatments , including approved GLP-1 therapies Healthcare professionals are not there to judge but to help you make informed, safe decisions

The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026